FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treatment of early cataract. A neutral bath of low-molecular peptide fraction that is prepared of acidic protein fraction of muscle extract of mammal lenses fractionated in 100% ammonium sulphate (Vilenzin) is instilled in conjunctival cavity. Instillations are carried out at 9, 12 and 17 o'clock, 2 drops in both eyes twice every 5 minutes within course 2-6 months every 10 days after 30 days.
EFFECT: method provides partial resorption and prevents progression of cataract.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOREGULATORY COMPLEX POSSESSING TISSUE-SPECIFIC REGENERATIVE ACTION, METHOD FOR PREPARING IT AND METHOD OF TREATING CATARACT USING IT | 2012 |
|
RU2513994C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTIVE MAINTENANCE OF DEVELOPMENT AND TREATMENT OF INITIAL STAGE OF AGE CATARACT (VERSIONS) | 2007 |
|
RU2352352C1 |
| EYE DROPS | 2009 |
|
RU2404768C1 |
| METHOD FOR PREPARING MEDICINAL AGENT FOR CATARACT TREATMENT | 2005 |
|
RU2315607C2 |
| METHOD FOR EXPERIMENTAL IN VIVO SIMULATION OF CORTICAL CATARACT | 2011 |
|
RU2553577C2 |
| ANTIOXIDANT AGENT FOR CATARACT TREATMENT | 2005 |
|
RU2297215C2 |
| METHOD FOR CATARACT TREATMENT AND EYE DROPS FOR IMPLEMENTATION THEREOF | 2016 |
|
RU2662364C2 |
| EYE DROPS FOR CATARACT TREATMENT | 1993 |
|
RU2071316C1 |
| COMPOSITION FOR CATARACT TREATMENT | 2005 |
|
RU2298408C2 |
| METHOD FOR PREDICTING THE COURSE OF CATARACT DEVELOPMENT AFTER PERFORMING ANTI-GLAUCOMA OPERATION | 1996 |
|
RU2115928C1 |
